JM

John Martin

Description

John Martin

Investor Profile

John Martin has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Chemical, Therapeutics.

Stage Focus

  • Seed (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Chemical
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does John Martin frequently co-invest with?

Omega Funds
Europe, Geneve, Switzerland, Geneva
Co-Investments: 1
Vida Ventures
North America, Massachusetts, United States, Boston
Co-Investments: 1
Bellco Capital
North America, California, United States, Los Angeles
Co-Investments: 1

Which angels does John Martin often collaborate with?

NB
North America, California, United States, San Mateo
Shared Deals: 1

What are some of recent deals done by John Martin?

Kronos Bio

San Mateo, California, United States

Kronos Bio focuses on the research and development of first-in-class therapies that modulate historically recalcitrant cancer.

BiotechnologyChemicalTherapeutics
SeedJun 5, 2018
Amount Raised: $18,000,000